Pulmonary embolism due to synthetic cannabinoid use: Case report
Year: 2022
Type: article
Study design: Case Report
Abstract: A 29-year-old male patient was treated and followed up for a pulmonary embolism. The patient had no relevant medical history, other than the fact that he had smoked bonzai, a synthetic cannabinoid derivative, for 2 years. Hypercoagulability tests were normal. The use of synthetic cannabinoids is increasing in the young population and should be kept in mind among the causes of pulmonary embolism.
Authors: Gokhan Yirgin, Ihsan Ates, Bilal Katipoglu, Burak Furkan Demir, Nisbet Yilmaz
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4226325666
